member
research
publication
photo
access
link
contact

 
 

20212020201920182017201620152014201320122011201020092008200720062005以前

  2014年度  
受賞歴   
  長野 一
  瀧 慎太郎
第8回若手医療薬科学シンポジウム優秀発表者賞
第13回次世代を担う若手医療薬科学シンポジウム優秀発表賞

原著論文
  鎌田 春彦

Nagano K., Maeda Y., Kanasaki S., Watanabe T., Yamashita T., Inoue M., Higashisaka K., Yoshioka Y., Abe Y., Mukai Y., Kamada H., Tsutsumi Y., Tsunoda S. : Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers., J. Controlled Release., 189:72-9, 2014.[PubMed]

Nagano K., Yamashita T., Inoue M., Higashisaka K., Yoshioka Y., Abe Y., Mukai Y., Kamada H., Tsutsumi Y., Tsunoda S. : Eph receptor A10 has a potential as a target for a prostate cancer therapy., Biochem. Biophys. Res. Commun., 450(1):545-9, 2014.[PubMed]

Yoshida T., Yoshioka Y., Takahashi H., Misato K., Mori T., Hirai T., Nagano K., Abe Y., Mukai Y., Kamada H., Tsunoda S., Nabeshi H., Yoshikawa T., Higashisaka K., Tsutsumi Y. : Intestinal absorption and biological effects of orally administered amorphous silica particles., Nanoscale Res Lett., 9:532, 2014.[PubMed]

Higashisaka K., Kunieda A., Iwahara Y., Tanaka K., Nagano K., Mukai Y., Kamada H., Tsunoda S., Yoshioka Y., Tsutsumi Y. : Neutrophilia due to silica nanoparticles induces release of double-stranded DNA., Journal of Nanomedicine & Nanotechnology., 5(5):1000236, 2014.

Imai S., Yoshioka Y., Morishita Y., Yoshida T., Uji M., Nagano K., Mukai Y., Kamada H., Tsunoda S., Higashisaka K., Tsutsumi Y. : Size and surface modification of amorphous silica particles determine their effects on the activity of human CYP3A4 in vitro., Nanoscale Res Lett., 9(1):651, 2014.[PubMed]

Hata K., Higashisaka K., Nagano K., Mukai Y., Kamada H., Tsunoda S., Yoshioka Y., Tsutsumi Y. : Evaluation of silica nanoparticle binding to major human blood proteins., Nanoscale Res Lett., 9:668, 2014.[PubMed]

Kamada H., Taki S., Nagano K., Inoue M., Ando D., Mukai Y., Higashisaka K., Yoshioka Y., Tsutsumi Y., Tsunoda S. : Generation and characterization of a bispecific Diabody targeting EPH receptor A10 and CD3., Biochem. Biophys. Res. Commun., 456(4):908-12, 2015.[PubMed]

Inoue M., Kamada H., Abe Y., Higashisaka K., Nagano K., Mukai Y., Yoshioka Y., Tsutsumi Y., Tsunoda S. : Aminopeptidase P3, a new member of the TNF-TNFR2 signaling complex, induces phosphorylation of JNK1 and JNK2., J. Cell Science, 128: 656-69, 2015.[PubMed]

Nagano K., Imai S., Zhao X., Yoshida., Yamashita T., Yoshioka Y., Abe Y., Mukai Y., Kamada H., Nakagawa S., Tsutsumi Y., Tsunoda S.: Identification and evaluation of metastasis-related proteins, oxysterol binding protein like 5 and calumenin, in lung tumor., Int. J. Oncol., 47:195-203,2015.[PubMed]

永田 諭志
Terrier B,* Nagata S,* Ise T, Rosenzwajg M, Pastan I, Klatzmann D, Saadoun D, Cacoub P (2014) Clonal CD21-/lo marginal zone-like B cells in HCV-related lymphoproliferation highly express Fc receptor-like 5 protein on the cell surface and are specifically killed by anti-FCRL5 immunotoxins, Arthritis & Rheumatism 66, 433-43.  (*equal contribution acknowledged).[PubMed]

Wysocka M, Kossenkov AV, Benoit BM, Troxel AB, Singer E, Schaffer A, Kim B, Dentchev T, Nagata S, Ise T, Showe LC, Rook AH (2014) CD164 and FCRL3 Are Highly Expressed on CD4+CD26- T Cells in Sézary Syndrome Patients, Journal of Investigative Dermatology 134, 229-236.
[PubMed]